5,6-Difluoroisobenzofuran-1,3-dione, 98.0%, 250mg

(2E)-3-(5-Oxo-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinolin-6-yl)acrylic acid, 95.0%, 50mg

TERT-BUTYL 4,6-DICHLORONICOTINATE, 95.0%, 1g

3-(4-Methoxy-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid, 95.0%, 1g

5,6,7,8-Tetrahydronaphthalen-1-ol, 95.0%, 25g

N-acetyl-3-(2,5-difluorophenyl)-D-alanine, 97.0%, 250mg

5,5-Dimethyl-2,4-oxazolidinedione>99.0%(GC)(T)5g

Thalidomide-O-C4-NH2 (hydrochloride), 50mg

(2-Chloropyridin-4-yl)methanamine hydrochloride, 95.0%, 250mg

(2R,6S)-rel-tert-Butyl 2,6-diethyl-4-oxopiperidine-1-carboxylate, 95.0%, 1g

Screw top bottle ROTILABO® brown glass, 100 ml, GL 45, 10 Piece(s)

5-Methyl-6-oxo-1,6-dihydropyridine-2-carboxylic acid, 95.0%, 1g

Diethyl ether, min. 99.5%, for synthesis, stab., 1L, glass packaging